132 related articles for article (PubMed ID: 23600748)
21. Gene therapy for alpha-fetoprotein-producing human hepatoma cells by adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene.
Kanai F; Shiratori Y; Yoshida Y; Wakimoto H; Hamada H; Kanegae Y; Saito I; Nakabayashi H; Tamaoki T; Tanaka T; Lan KH; Kato N; Shiina S; Omata M
Hepatology; 1996 Jun; 23(6):1359-68. PubMed ID: 8675152
[TBL] [Abstract][Full Text] [Related]
22. Alpha-fetoprotein-mediated uptake of fatty acids by human T lymphocytes.
Torres JM; Anel A; Uriel J
J Cell Physiol; 1992 Mar; 150(3):456-62. PubMed ID: 1371512
[TBL] [Abstract][Full Text] [Related]
23. Gene therapy for hepatoma cells using a retrovirus vector carrying herpes simplex virus thymidine kinase gene under the control of human alpha-fetoprotein gene promoter.
Ido A; Nakata K; Kato Y; Nakao K; Murata K; Fujita M; Ishii N; Tamaoki T; Shiku H; Nagataki S
Cancer Res; 1995 Jul; 55(14):3105-9. PubMed ID: 7541712
[TBL] [Abstract][Full Text] [Related]
24. Alpha-fetoprotein-mediated targeting of anti-cancer drugs to tumor cells in vitro.
Severin SE; Moskaleva EYu ; Shmyrev II; Posypanova GA; Belousova YuV ; Sologub VK; Luzhkov YuM ; Nakachian R; Andreani J; Severin ES
Biochem Mol Biol Int; 1995 Oct; 37(2):385-92. PubMed ID: 8673023
[TBL] [Abstract][Full Text] [Related]
25. [Research advances on alpha-fetoprotein physiological function and clinical potential].
Yin ZF; Wang CH
Ai Zheng; 2003 Jan; 22(1):108-11. PubMed ID: 12561448
[TBL] [Abstract][Full Text] [Related]
26. Retrovirus-mediated gene therapy for hepatocellular carcinoma: selective and enhanced suicide gene expression regulated by human alpha-fetoprotein enhancer directly linked to its promoter.
Mawatari F; Tsuruta S; Ido A; Ueki T; Nakao K; Kato Y; Tamaoki T; Ishii N; Nakata K
Cancer Gene Ther; 1998; 5(5):301-6. PubMed ID: 9824049
[TBL] [Abstract][Full Text] [Related]
27. An apparent dimerization motif in the third domain of alpha-fetoprotein: molecular mimicry of the steroid/thyroid nuclear receptor superfamily.
Mizejewski GJ
Bioessays; 1993 Jun; 15(6):427-32. PubMed ID: 7689318
[TBL] [Abstract][Full Text] [Related]
28. The alpha-fetoprotein (AFP) third domain: a search for AFP interaction sites of cell cycle proteins.
Mizejewski GJ
Tumour Biol; 2016 Sep; 37(9):12697-12711. PubMed ID: 27448301
[TBL] [Abstract][Full Text] [Related]
29. Alpha-fetoprotein-mediated targeting--a new strategy to overcome multidrug resistance of tumour cells in vitro.
Moskaleva EYu ; Posypanova GA; Shmyrev II; Rodina AV; Muizhnek EL; Severin ES; Katukov VYu ; Luzhkov YM; Severin SE
Cell Biol Int; 1997 Dec; 21(12):793-9. PubMed ID: 9812343
[TBL] [Abstract][Full Text] [Related]
30. Isolation and partial characterization of a specific alpha-fetoprotein receptor on human monocytes.
Suzuki Y; Zeng CQ; Alpert E
J Clin Invest; 1992 Oct; 90(4):1530-6. PubMed ID: 1383274
[TBL] [Abstract][Full Text] [Related]
31. Endocytosis of three serum proteins of a multigene family and of arachidonic acid in human lectin-stimulated T lymphocytes.
Geuskens M; Torres JM; Esteban C; Uriel J
Microsc Res Tech; 1994 Jul; 28(4):297-307. PubMed ID: 7522654
[TBL] [Abstract][Full Text] [Related]
32. A LDL-masked liposomal-doxorubicin reverses drug resistance in human cancer cells.
Kopecka J; Campia I; Olivero P; Pescarmona G; Ghigo D; Bosia A; Riganti C
J Control Release; 2011 Jan; 149(2):196-205. PubMed ID: 20946921
[TBL] [Abstract][Full Text] [Related]
33. Targeting gene therapy for hepatocarcinoma cells with the E. coli purine nucleoside phosphorylase suicide gene system directed by a chimeric alpha-fetoprotein promoter.
Cai X; Zhou J; Chang Y; Sun X; Li P; Lin J
Cancer Lett; 2008 Jun; 264(1):71-82. PubMed ID: 18407409
[TBL] [Abstract][Full Text] [Related]
34. Alphafetoprotein and alphafetoprotein receptor expression in the normal human placenta at term.
Newby D; Dalgliesh G; Lyall F; Aitken DA
Placenta; 2005; 26(2-3):190-200. PubMed ID: 15708120
[TBL] [Abstract][Full Text] [Related]
35. Review and proposed action of alpha-fetoprotein growth inhibitory peptides as estrogen and cytoskeleton-associated factors.
Mizejewski G; Smith G; Butterstein G
Cell Biol Int; 2004; 28(12):913-33. PubMed ID: 15566961
[TBL] [Abstract][Full Text] [Related]
36. [Construction and expression of human alpha-fetoprotein recombinant plasmid].
Deng XL; Cai MY; Wei DP; Hu LJ; Bi JH; Yuan T
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Sep; 35(5):612-4, 633. PubMed ID: 15460399
[TBL] [Abstract][Full Text] [Related]
37. The alpha-fetoprotein third domain receptor binding fragment: in search of scavenger and associated receptor targets.
Mizejewski GJ
J Drug Target; 2015; 23(6):538-51. PubMed ID: 25766080
[TBL] [Abstract][Full Text] [Related]
38. Ultrastructural studies of the intracellular translocation of endocytosed alpha-foetoprotein (AFP) by cytochemistry and of the uptake of 3H-arachidonic acid bound to AFP by autoradiography in rat rhabdomyosarcoma cells.
Geuskens M; Naval J; Uriel J
J Cell Physiol; 1986 Sep; 128(3):389-96. PubMed ID: 2427529
[TBL] [Abstract][Full Text] [Related]
39. In vivo bioluminescent imaging of α-fetoprotein-producing hepatocellular carcinoma in the diethylnitrosamine-treated mouse using recombinant adenoviral vector.
Kim KI; Park JH; Lee YJ; Lee TS; Park JJ; Song I; Nahm SS; Cheon GJ; Lim SM; Chung JK; Kang JH
J Gene Med; 2012 Aug; 14(8):513-20. PubMed ID: 22761128
[TBL] [Abstract][Full Text] [Related]
40. Binding and internalization of NGR-peptide-targeted liposomal doxorubicin (TVT-DOX) in CD13-expressing cells and its antitumor effects.
Garde SV; Forté AJ; Ge M; Lepekhin EA; Panchal CJ; Rabbani SA; Wu JJ
Anticancer Drugs; 2007 Nov; 18(10):1189-200. PubMed ID: 17893520
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
